|
1
|
(D4) Determine barriers and facilitators to mental health screening for pediatric patients with rheumatologic disease.
|
4.3 (±0.8)
|
|
2
|
(D2) Determine the accuracy of mental health screening tools for identifying mental health conditions in specific rheumatology disease populations.
|
4.2 (±0.8)
|
|
3
|
(A1) Determine the prevalence and incidence of mental health disorders in pediatric patients with rheumatologic disease, as well as socio-demographic and disease-specific risk factors.
|
4.1 (±0.8)
|
|
4
|
(D1) Determine which mental health conditions are most important to screen for in pediatric patients with rheumatologic disease.
|
4.1 (±0.8)
|
